Irene Ghobrial, M.D.

Dr. Irene Ghobrial is an Assistant Professor at Harvard Medical School. She received her MD in 1995 from Cairo University. She completed her residency in internal medicine at Wayne State University, Sinai-Grace Hospital in Detroit, Michigan, and her hematology/oncology fellowship at the Mayo Clinic in Rochester, Minnesota. She joined DFCI in October, 2005. Here, her basic science and clinical work focuses on the development of novel therapeutic agents for the treatment of Waldenstrom’s and multiple myeloma, with particular interest in the PI3K/AKT/mTOR pathway. She also has a special interest in the role of chemokine receptor CXCR4 in the migration and homing of multiple myeloma and Waldenström’s.

Dr. Ghobrial is the recipient of the American Society of Hematology Scholar Award, the American Society of Clinical Oncology Foundation Young Investigator Award, and a Smokler Award from the Research Fund for Waldenstrom Foundation. She is also a Leukemia and Lymphoma Society scholar and a Lymphoma Research Foundation scholar.

Currently, Dr. Ghobrial oversees the Kirsch Laboratory for Waldenstrom's, a lab within the Bing Center for Waldenstrom's macroglobulinemia.

Click this link to display Dr. Ghobrial's DFCI profile and contact information.

Click this link for WM clinical trials under Dr. Ghobrial.